StockData
Evolent Health, Inc. logo

Evolent Health, Inc. (EVH) stock

EVHNYSEServices-Management ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3055% below fair value
$4.62−0.21 (-4.35%)

Close on Nov 17, 2026Market cap $522.33MP/E –Yield –

Evolent Health operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Evolent Health's operating cash flow for the twelve months ending Jun 30, 2026 was $54.32M. For fiscal 2025 it was $38.84M, up 107.0% from the year before. The highest annual figure on record is $142.58M in fiscal 2023.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$38.84M+107.0%
FY2024Dec 31, 2024$18.77M-86.8%
FY2023Dec 31, 2023$142.58M–
FY2022Dec 31, 2022-$11.55M-129.8%
FY2021Dec 31, 2021$38.75M–
FY2020Dec 31, 2020-$16.23M–
FY2019Dec 31, 2019-$42.65M–
FY2018Dec 31, 2018-$20.65M–
FY2017Dec 31, 2017-$27.96M–
FY2016Dec 31, 2016-$35.51M–
FY2015Dec 31, 2015-$18.47M–
FY2014Dec 31, 2014$0–
FY2013Dec 31, 2013-$13.63M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$9.31M–
Q1 FY2026Mar 31, 2026-$984.00K-121.6%
Q4 FY2025Dec 31, 2025$48.80M–
Q3 FY2025Sep 30, 2025$15.81M-15.3%
Q2 FY2025Jun 30, 2025-$30.33M-241.6%
Q1 FY2025Mar 31, 2025$4.57M-7.0%
Q4 FY2024Dec 31, 2024-$26.23M-129.3%
Q3 FY2024Sep 30, 2024$18.67M-69.2%
Q2 FY2024Jun 30, 2024$21.42M+3174.8%
Q1 FY2024Mar 31, 2024$4.91M–
Q4 FY2023Dec 31, 2023$89.38M+150.4%
Q3 FY2023Sep 30, 2023$60.52M–
Q2 FY2023Jun 30, 2023$654.00K-95.2%
Q1 FY2023Mar 31, 2023-$7.97M–
Q4 FY2022Dec 31, 2022$35.70M-46.4%
Q3 FY2022Sep 30, 2022-$3.47M-107.8%
Q2 FY2022Jun 30, 2022$13.66M–
Q1 FY2022Mar 31, 2022-$57.44M–
Q4 FY2021Dec 31, 2021$66.66M–
Q3 FY2021Sep 30, 2021$44.50M–
Q2 FY2021Jun 30, 2021-$24.25M-164.4%
Q1 FY2021Mar 31, 2021-$48.16M–
Q4 FY2020Dec 31, 2020-$12.85M-197.5%
Q3 FY2020Sep 30, 2020-$20.50M–
Q2 FY2020Jun 30, 2020$37.67M–
Q1 FY2020Mar 31, 2020-$20.54M–
Q4 FY2019Dec 31, 2019$13.19M–
Q3 FY2019Sep 30, 2019-$16.59M-174.3%
Q2 FY2019Jun 30, 2019-$13.53M-302.0%
Q1 FY2019Mar 31, 2019-$25.71M–
Q4 FY2018Dec 31, 2018-$24.97M-513.7%
Q3 FY2018Sep 30, 2018$22.32M+484.5%
Q2 FY2018Jun 30, 2018$6.70M–
Q1 FY2018Mar 31, 2018-$24.71M–
Q4 FY2017Dec 31, 2017$6.04M–
Q3 FY2017Sep 30, 2017$3.82M-51.7%
Q2 FY2017Jun 30, 2017-$3.05M–
Q1 FY2017Mar 31, 2017-$34.77M–
Q4 FY2016Dec 31, 2016-$21.51M–
Q3 FY2016Sep 30, 2016$7.91M–

More Evolent Health figures

See a number that looks wrong?